Antipsychotic Drugs Market 2020 Global Leading Players Future Analysis, Trends, Industry Updates and Forecast 2026

The schizophrenia segment emerged dominant in the global “antipsychotic drugs market Share” in 2018. The segment had acquired an astonishing 45.2% of the global antipsychotic drugs market share in the same year owing to the rising prevalence of the disorder. This information is published in a report by Fortune Business Insights, titled, “Antipsychotic Drugs: Global Market Analysis, Insights and Forecast, 2019-2026.” According to the report, the global market was worth US$ 14,963.5 Mn in 2018. However, Fortune Business Insights predicts that the global market will reach US$ 20,539.5 Mn by 2026, exhibiting a CAGR of 4.0% in the forecast period.
The report on antipsychotic drugs market provides insights into growth opportunities for investors and businesses alike and growth drivers and trends in the market. It offers quantitative and qualitative information on the drivers and growth rate of the segments in the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antipsychotic-drugs-market-101390

Leading Players operating in the Antipsychotic Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• H. Lundbeck A/S
• Otsuka Pharmaceutical Co., Ltd.
• Janssen Pharmaceuticals, Inc.
• Eli Lilly and Company
• AstraZeneca
• ALLERGAN
• Vanda Pharmaceuticals Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Alkermes plc
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Other Prominent Players

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this .
Please visit: https://www.fortunebusinessinsights.com/industry-reports/antipsychotic-drugs-market-101390

Rapid Shift Towards Advanced and Safe Drugs to Favor Growth in North America
Geographically, the global antipsychotic drugs market is grouped into Latin America, Asia Pacific, North America, the Middle East and Africa, and Europe. Amongst these regions, North America had acquired US$ 9,307.3 Mn antipsychotic drugs market revenue in the year 2018. The growth is attributed to the increasing patient pool suffering from psychotic disorders in the region. Additionally, a rapid shift of these patients towards safe antipsychotic drugs for the treatment of schizophrenia, bipolar disorder, and other psychotic diseases is expected to drive the antipsychotic drugs market in this region. Several healthcare organizations in North America have also begun promoting such drugs for treatment.

Detailed Table of Content:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Overview of Prevalence of Psychiatric Disorders by Key Regions
4.2. Pipeline Analysis
4.3. Key Industry Developments
4.4. New Product Launches
4.5. Analysis of the Cost and Burden of Mental Health Disorders
4.6. Analysis of Antipsychotics in Treatment of Dementia
4.7. Analysis of First Generation Antipsychotics versus Second & Third Generation Antipsychotics
4.8. Overview of R&D Initiatives
5. Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Disease
5.2.1. Schizophrenia
5.2.2. Bipolar Disorder
5.2.3. Unipolar Depression
5.2.4. Dementia
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By Therapeutic Class
5.3.1. First Generation
5.3.2. Second Generation
5.3.3. Third Generation
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies
5.4.3. Online Pharmacies
5.4.4. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Disease
6.2.1. Schizophrenia
6.2.2. Bipolar Disorder
6.2.3. Unipolar Depression
6.2.4. Dementia
6.2.5. Others
6.3. Market Analysis – By Therapeutic Class
6.3.1. First Generation
6.3.2. Second Generation
6.3.3. Third Generation
6.4. Market Analysis – By Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Others
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Disease
7.2.1. Schizophrenia
7.2.2. Bipolar Disorder
7.2.3. Unipolar Depression
7.2.4. Dementia
7.2.5. Others
7.3. Market Analysis – By Therapeutic Class
7.3.1. First Generation
7.3.2. Second Generation
7.3.3. Third Generation
7.4. Market Analysis – By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
7.4.4. Others
7.5. Market Analysis – By Country
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Disease
8.2.1. Schizophrenia
8.2.2. Bipolar Disorder
8.2.3. Unipolar Depression
8.2.4. Dementia
8.2.5. Others
8.3. Market Analysis – By Therapeutic Class
8.3.1. First Generation
8.3.2. Second Generation
8.3.3. Third Generation
8.4. Market Analysis – By Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
8.4.4. Others
8.5. Market Analysis – By Country/ Sub-Region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
Continued...

Market Segmentation:
By Disease
• Schizophrenia
• Bipolar Disorder
• Unipolar Depression
• Dementia
• Others
By Therapeutic Class
• First Generation
• Second Generation
• Third Generation
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
By Geography
• North America (the USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Reasons to Purchase this Report:

• Comprehensive analysis of the Antipsychotic Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antipsychotic-drugs-market-101390

KEY QUESTIONS ANSWERED:

• What are the key technological and Antipsychotic Drugs Market trends shaping the market?
• What are the key opportunities in the market?
• What are the key companies operating in the market?
• Which company accounted for the highest market share?
• Why Choose Fortune Business Insights?
• What is the market size and growth rate of the global and regional market by various segments?
• What is the market size and growth rate of the market for selective countries?
• Which region or sub-segment is expected to drive the market in the forecast period?
• What Factors are estimated to drive and restrain the Antipsychotic Drugs Market growth?

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.